Professional manufacturer supply Citrus grandis (L.) Osbeck extract Apigenin 99% In bulk CAS NO 520-36-5

Introduction to Apigenin (520-36-5): Apigenin (520-36-5) is a natural flavonoid compound widely distributed in various fruits, vegetables, and herbs. Its distinct chemical structure and pharmacological properties have garnered significant attention in biomedical research for its potential health benefits.

Chemical Structure of Apigenin (520-36-5): Apigenin (520-36-5) belongs to the flavone subclass of flavonoids, characterized by a 2-phenylchromen-4-one backbone with hydroxyl groups at positions 5, 7, and 4'. This molecular arrangement contributes to its antioxidant and anti-inflammatory activities.

Natural Sources of Apigenin (520-36-5): Apigenin (520-36-5) is abundant in a variety of plant-based foods, including parsley, celery, chamomile, and oranges. Its presence in dietary sources underscores its potential role in promoting human health through nutritional interventions.

Biological Activities of Apigenin (520-36-5): Apigenin (520-36-5) exhibits a diverse array of biological activities, including antioxidant, anti-inflammatory, anticancer, and neuroprotective effects. These multifaceted properties make it a promising candidate for therapeutic development.

Antioxidant Properties of Apigenin (520-36-5): Apigenin (520-36-5) functions as a potent antioxidant by scavenging free radicals and reactive oxygen species, thereby protecting cells from oxidative damage and reducing the risk of chronic diseases such as cancer and cardiovascular disorders.

Anti-Inflammatory Effects of Apigenin (520-36-5): Apigenin (520-36-5) exerts anti-inflammatory effects by modulating inflammatory signaling pathways and inhibiting the production of pro-inflammatory mediators such as cytokines and chemokines. This anti-inflammatory activity contributes to its potential therapeutic utility in inflammatory conditions.

Anticancer Potential of Apigenin (520-36-5): Preclinical studies have highlighted the anticancer properties of apigenin (520-36-5), including its ability to inhibit cancer cell proliferation, induce apoptosis, and suppress tumor growth and metastasis. These findings suggest its potential as an adjuvant therapy for cancer treatment.

Neuroprotective Effects of Apigenin (520-36-5): Apigenin (520-36-5) demonstrates neuroprotective effects by attenuating oxidative stress, reducing neuroinflammation, and promoting neuronal survival and synaptic plasticity. These neuroprotective properties hold promise for mitigating neurodegenerative diseases such as Alzheimer's and Parkinson's.

Pharmacokinetics of Apigenin (520-36-5): The pharmacokinetic profile of apigenin (520-36-5) includes absorption, distribution, metabolism, and excretion processes, which influence its bioavailability and therapeutic efficacy in vivo. Understanding these pharmacokinetic parameters is crucial for optimizing its clinical use.

Clinical Studies on Apigenin (520-36-5): Although most research on apigenin (520-36-5) has been preclinical, a growing number of clinical studies are investigating its potential therapeutic applications in humans. These studies explore its safety, efficacy, and dose-response relationships in various health conditions.

Formulation Considerations for Apigenin (520-36-5): Formulation strategies such as encapsulation, nanoparticle delivery, and prodrug design are being explored to enhance the bioavailability and stability of apigenin (520-36-5) for therapeutic purposes. These approaches aim to overcome limitations associated with its poor solubility and rapid metabolism.

Safety Profile of Apigenin (520-36-5): Apigenin (520-36-5) is generally regarded as safe when consumed in dietary amounts, with no significant adverse effects reported. However, further research is needed to evaluate its long-term safety and potential drug interactions in clinical settings.

Regulatory Status of Apigenin (520-36-5): Apigenin (520-36-5) is classified as a dietary supplement by regulatory agencies in many countries, allowing its incorporation into food products and nutraceutical formulations. However, regulatory requirements may vary depending on the intended use and marketing claims.

Future Directions in Apigenin Research: Future research directions for apigenin (520-36-5) encompass elucidating its molecular mechanisms of action, optimizing its pharmacokinetic properties, and exploring innovative therapeutic applications in precision medicine and personalized healthcare.

Collaborative Efforts in Apigenin Research: Collaborative initiatives involving multidisciplinary teams of scientists, clinicians, and industry partners are essential for advancing apigenin (520-36-5) research from bench to bedside. These collaborative efforts facilitate knowledge exchange, resource sharing, and translational research to accelerate therapeutic innovation.